BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31752459)

  • 1. [Clinical characteristics and diagnosis of early hydatidiform mole].
    Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of centralized surveillance of hydatidiform mole].
    Jiao LZ; Wang YP; Jiang JY; Zhang WQ; Wang XY; Zhu CG; Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):390-395. PubMed ID: 29961281
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.
    Tang Y; Zhu C; Zhu C; Liang F; Lee A; Yao X; Chen Q
    BMC Womens Health; 2020 Sep; 20(1):196. PubMed ID: 32912152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
    Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
    Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
    Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center.
    Fowler DJ; Lindsay I; Seckl MJ; Sebire NJ
    Ultrasound Obstet Gynecol; 2006 Jan; 27(1):56-60. PubMed ID: 16273594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current clinical features of complete and partial hydatidiform mole in Sweden.
    Joneborg U; Marions L
    J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women.
    Mangili G; Giorgione V; Gentile C; Bergamini A; Pella F; Almirante G; Candiani M
    Acta Obstet Gynecol Scand; 2014 May; 93(5):503-7. PubMed ID: 24575838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of clinical features in hydatidiform mole: analysis of 113 cases.
    Hou JL; Wan XR; Xiang Y; Qi QW; Yang XY
    J Reprod Med; 2008 Aug; 53(8):629-33. PubMed ID: 18773629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical presentation of molar pregnancy.
    Langhe R; Muresan BA; Akpan E; Abdul Wahab NA
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30262528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of complete and partial molar pregnancy.
    Goldstein DP; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.